Columbia, South Carolina 29223


Purpose:

There is emerging evidence that an excessive amount of sitting is linked with an increased risk of negative health outcomes independent of an individual's physical activity levels. This is concerning considering data indicate Americans spend over half of the waking day engaged in sedentary activities, and that individuals who are overweight or obese and/or have a chronic disease such as hypertension are likely to have an even higher level of sedentary behavior. A limited number of experimental studies have looked at the effects of reducing sitting time on blood pressure and have shown promise. However, these studies lasted for only a day, so it is unclear how reducing sedentary time may influence blood pressure over a longer duration. The purpose of this study is to look the relationships between the amount of time a person spends sitting and their blood pressure and examine whether decreasing sedentary behavior helps improve blood pressure. The study employs the use of coaching calls and a mobile health (mHealth) intervention to reduce the sedentary behavior of participants through strategies such as prompting, feedback, and counseling.


Study summary:

The purpose of this study is to determine the effect of a 4-week sedentary behavior reduction intervention on objectively measured sedentary behavior of overweight or obese adults with controlled hypertension. The proposed study is a pilot, proof-of-concept randomized controlled trial that will randomize participants to either the 1) Immediate Intervention group, which will receive coaching calls + a mHealth intervention for the first four weeks of the study and then will receive only the mHealth intervention for the remaining 4 weeks or the 2) Delayed Intervention Control group, which will act as an assessment-only condition for the first 4 weeks and then will receive the coaching calls + mHealth intervention for 4-weeks. This design has two phases: Phase 1, which is a randomized controlled feasibility pilot and the primary study focus, followed by Phase 2, which is an exploratory phase, allowing replication of the intervention (in the Delayed Intervention Control group) and extended follow-up (in the Immediate Intervention group). The study outcomes to be investigated in Phase 1 include: - 1) the change in total % sedentary time from baseline to the 4-week assessment, comparing the average proportion of objectively-measured time spent sitting during the waking day across the previous week in the Immediate Intervention group (which will have received the 4-week coaching calls + mHealth sedentary behavior reduction intervention) with the average proportion of objectively-measured waking sedentary time across the previous week in the Delayed Intervention Control group (which will have received assessment only during this period). - 2) the change in blood pressure, comparing the Immediate Intervention group (which will have received the 4-week coaching calls + mHealth sedentary behavior reduction intervention) with the Delayed Intervention Control group (which will have received assessment only during this period). - 3) Process data on participant recruitment to the study, and, among those randomized to the Immediate intervention, engagement with the intervention (e.g., response rates to the texts, completion of intervention phone calls, etc.), and participant evaluation of the intervention. The study outcomes to be investigated in Phase 2 include: - 1) Objectively measured sedentary behavior in the Immediate Intervention group 4 weeks post-treatment (i.e. at 8-week assessment), allowing quantification of maintenance of sedentary behavior reduction following the termination of coaching calls. - 2) Objectively-measured sedentary behavior and blood pressure at 8 weeks post randomization in the Delayed Intervention Control group (i.e. following implementation of the 4-week coaching calls+ mHealth intervention), allowing assessment of whether intervention effects are reproducible.


Criteria:

Inclusion Criteria: - Being 18 years or older - Having a BMI between 25 and 50 kg/m2 - Having controlled hypertension, which will be verified by measuring blood pressure at baseline and by proof of current (prescribed within the past 6 months) hypertension medication. - Having visited a physician within the last 6 months - Owning a smartphone that is accessible during the day - Living or working within 30 miles of University of South Carolina (USC) - Willing to wear the activPAL for baseline assessment - An average self-reported sedentary time of at least 7 hours over the past 7 days - Willing to be randomized to either group Exclusion Criteria: - Inability to walk without assistance - Recent use of psychotropic medications or treatment for psychological issues, with the exception of anxiety and depression - Current treatment for cancer or other serious medical conditions such as renal failure - Injury or illness that prohibits standing or walking - Pregnant or gave birth within the last 6 months - Does not live or work within 30 miles of USC - Currently enrolled in a weight loss, physical activity, or stress management program - A known vacation or a major alteration in their normal schedule in the next 4 months - Unwilling to wear the accelerometer for 7 days at any assessment period or had an adverse reaction to wearing the accelerometer during baseline


NCT ID:

NCT03698903


Primary Contact:

Principal Investigator
Chelsea Larsen, MPH
University of South Carolina

Chelsea Larsen, MPH
Phone: 803-777-2702
Email: calarsen@email.sc.edu


Backup Contact:

N/A


Location Contact:

Columbia, South Carolina 29223
United States

Chelsea Larsen, MPH
Phone: 803-777-2702
Email: calarsen@email.sc.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.